Dr. Gregory StockProfessor in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine - Co-Director of the Harris Center for Precision Wellness at Mount Sinai’s Institute of Nextgen Healthcare
Dr. Gregory Stock – a professor in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine – co-directs the Harris Center for Precision Wellness at Mount Sinai’s Institute of Nextgen Healthcare. A leading authority on the impacts of genomic and other advanced technologies in the life sciences, Stock has a PhD from Johns Hopkins and an MBA from Harvard Business School. He was a senior fellow at Princeton’s Woodrow Wilson School of Public Policy and the founding director of UCLA’s program on Medicine, Technology, and Society. He was the founding CEO of Signum Biosciences, a biotech company developing therapeutics for neurodegenerative disease, and Ecoeos, which pioneered consumer testing for genetic susceptibility to Hg exposure. Stock has written 9 books including Redesigning Humans: Our Inevitable Genetic Future, which won the Kistler Prize for science writing, Metaman: the Merging of Humans and Machines into a Global Superorganism, and The Book of Questions, which has sold 3 million copies and been translated into 20 languages. Stock has engaged in healthcare policy debates with figures ranging from Francis Fukuyama to Ray Kurzweil, spoken at TED, TEDMED, and PopTech, and appeared frequently on shows such as Charlie Rose, Talk of the Nation, Science Friday, Larry King and Oprah Winfrey.